Hosted on MSN1y
FDA’s Marks says global dialogue on gene therapy regulation key for patient access
according to the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research director Peter Marks. Marks was speaking at a panel discussion on the regulatory landscape ...
STAT14dOpinion
How will the Center for Biologics Evaluation and Research change under RFK Jr.?
At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...
Hosted on MSN6mon
FDA approves first self-administered flu vaccine spray
flexibility and accessibility," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a statement. The FluMist vaccine, manufactured by AstraZeneca ...